Premenstrual Syndrome
Conditions
Brief summary
The objective of the present study is to better define and evaluate Serelys PMS in terms of the impact on the different premenstrual syndrome (PMS) symptoms , tolerance, satisfaction and overall quality of life of women with known discomforts during the premenstrual period. The data from this study will be compared to data when the two different ingredients are given as monotherapy.
Detailed description
More than every other women aged 15 to 50 years of age have premenstrual symptoms such as irritability, mood swings, fatigue, headaches, sleep disturbances, breast and abdominal pain, bloating, water retention and weight gain. Some signs continue during menstruation. These psychological and physical manifestations can make women vulnerable and have a negative impact on their professional, social and sexual life. Randomized, double-blind, placebo-controlled clinical studies demonstrated the beneficial effects of pollen extract in premenstrual discomfort. The premenstrual period is probably caused by a change in the normal amount of sex hormones which can induce disorders in the central neuroendocrine system and estrogens are reported to reduce PMS symptoms to some extend. Moreover, it is well established that serotonin may play a role in PMS, as some inhibitors of serotonin re-uptake (SSRI) have an impact on premenstrual disorders. However, side effects may occur even when using estrogens as well as SSRI. Recently the pollen extract formulation has been improved by adding a natural extract of saffron. This latter component is known for its beneficial action on maintaining comfort during the menstrual cycle of the woman and it especially supports mood changes, one of the mayor PMS symptoms. The effect of Safran was studied more specifically in a randomized controlled double-blind, placebo-controlled clinical trial in women with premenstrual discomfort. This study showed a progressive and significant improvement after the use of saffron. In an other study saffron was documented to improve mood in patients with milder depression. In summary, the components of saffron helps to improve the well-being of women during the premenstrual and menstrual period and have a well documented impact on mood. The pollen based extracts have well documented impact on most of PMS symptoms but possibly lesser on mood changes, which is also one of the mayor symptoms of PMS. The mechanisms by which saffron and pollen based extraction works is expected to be different and an additive impact is expected. The investigation is initiated by the researchers who feel that in PMS an alternatives to SSRI and estrogen treatment is needed.
Interventions
DIETARY_SUPPLEMENTPlacebo
2 months treatment
DIETARY_SUPPLEMENTSerelys PMS
2 months treatment
Sponsors
Serelys Pharma
Jens Rikardt Andersen
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Masking description
Placebo controlled
Intervention model description
2 months treatment with (Food Supplement - Serelys PMS)
Eligibility
Sex/Gender
FEMALE
Age
21 Years to 50 Years
Healthy volunteers
Yes
Inclusion criteria
* At least five inconveniences in the premenstrual period and which disappear quickly with the end of menstruation : Irritability, Tension, Fatigue, Dysphoria (sadness), Reduced motor coordination, Difficulty concentrating, Changes in libido, Changes in appetite. * these inconveniences disappear quickly with the end of menstruation * At least one of these criteria must be present in the premenstrual and menstrual period: 1. Deterioration in relations with the family, at home, in school or at work 2. Having thought to take painkillers for at least one menstrual cycle. * Have symptoms of dysphoria / premenstrual sadness at least during the previous 6 cycles.
Exclusion criteria
* Known allergy to any component of the product and known renal and hepatic impairment. * Existence of major evolving pathologies * Convulsions. Existence of psychiatric disorders, cravings * Suicidal thoughts * Taking medications that may interfere with PMS symptoms like eg estrogens. * Participation in another clinical study at the same time. * Pregnancy and / or lactation; * Difficulties to collaborate and difficulties to understand and complete the questionnaires.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| PMS symptoms evaluation - Premenstrual Tension | 2 months | Premenstrual Tension Scale (PMTS) - Self-rating scale |
| PMS symptoms evaluation - Premenstrual Tension 2 | 2 months | Premenstrual Tension Scale (PMTS) - Observe Rating Scale |
| PMS symptoms evaluation - premenstrual discomfort | 2 months | Evaluation of premenstrual discomfort by Visual Analog Scales (VAS) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Side effect registration | 2 months | Tolerance will be assessed through a scoring system |
| Satisfaction scored by the patients | 2 months | Satisfaction and well-being will be assessed through a scoring system |
Countries
Denmark
Outcome results
None listed